Clinical Trial Update: Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL) [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating rituximab with CVP chemotherapy plus interferon for follicular non-Hodgkin lymphoma, which has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Interferon alfa-2b (interferon alfa-2b)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fundación Leucemia y Linfoma, Spain | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED